InvestorsHub Logo
Followers 6
Posts 3891
Boards Moderated 0
Alias Born 01/14/2001

Re: None

Friday, 09/01/2006 3:48:39 AM

Friday, September 01, 2006 3:48:39 AM

Post# of 82595
DNAPrint Pharmaceuticals Completes The Development Of A Second Assay For Its Anemia Drug
DNAPrint Genomics, Inc. (OTCBB: DNAG) today announced that KBI BioPharma, Inc., has completed and validated a second analytical method for PT-401, based on SDS-PAGE, a well established separation technique that will be used for in-process analysis, release and stability testing for its PT-401 anemia drug, which is being developed by its subsidiary, DNAPrint Pharmaceuticals, Inc.
(See Story from BioSpace.com) (08/04/2006)

Ann